Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Merck
Queensland Health
Covington
Baxter
Colorcon
Teva
Dow
Fuji

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,412,095

« Back to Dashboard

Summary for Patent: 5,412,095
Title: Terazosin monohydrochloride and processes and intermediate for its production
Abstract:The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystalline forms of terazosin monohydrochloride.
Inventor(s): Morley; James A. (Gurnee, IL), Bauer; John F. (Lake Bluff, IL), Patel; Ramesh F. (Chicago, IL), Henry; Rodger E. (Waukegan, IL), Spanton; Stephen G. (Grayslake, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:08/246,526
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 5,412,095

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,412,095

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 130853 ➤ Subscribe
Austria 182592 ➤ Subscribe
Canada 2107382 ➤ Subscribe
Canada 2143974 ➤ Subscribe
Germany 623612 ➤ Subscribe
Germany 683167 ➤ Subscribe
Germany 69300913 ➤ Subscribe
Germany 69428933 ➤ Subscribe
Germany 69510999 ➤ Subscribe
Germany 9320931 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Healthtrust
Boehringer Ingelheim
Cantor Fitzgerald
Queensland Health
Daiichi Sankyo
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot